Home > Financial Ratios > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Price to Cash Earnings (PCE)

    Back to All Ratios
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
   PCE(x) 6.537.707.08-6.31-

What is the latest Price to Cash Earnings (PCE) ratio of NATH BIOGENES (INDIA) ?

The latest Price to Cash Earnings (PCE) ratio of NATH BIOGENES (INDIA) is 6.53 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar20256.53
Mar20247.70
Mar20237.08
Mar2022-6.31
Mar2013-

How is Price to Cash Earnings (PCE) of NATH BIOGENES (INDIA) Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 6.53
-15.19
Mar2024 7.7
8.76
Mar2023 7.08
Positive
Mar2022 -6.31
0
Mar2013 0 -

Other Financial Ratios of NATH BIOGENES (INDIA)


Compare Price to Cash Earnings (PCE) ratio of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹338.2 Cr 2.4% -6.9% -23.8% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹12,729.9 Cr -1.4% -7.9% -26.7% Stock Analytics
KAVERI SEED COMPANY ₹5,989.1 Cr 8.2% 4.1% 2.2% Stock Analytics
VENKYS (INDIA) ₹2,118.5 Cr 7.1% -3.4% -36.1% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,455.8 Cr 5.9% 1.3% -30.4% Stock Analytics
INDO US BIOTECH ₹302.8 Cr -4.4% -15% -45.5% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

2.4%

-6.9%

-23.8%

SENSEX

0.9%

-1.1%

0.6%


You may also like the below Video Courses